{"transactions":[{"id":691890,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25019,"kind":"person","name":"Harsanyi Zsolt","position":1,"cik":"0001380184","reported_name":"Harsanyi Zsolt","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2026-08-11T01:39:05.000Z","date":"2026-08-06","kind":"exercise","planned":false,"acquired":false,"shares":400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On August 6, 2025, the reporting person was granted 7,200 (400 post-split) RSUs, vesting on the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On August 6, 2025, the reporting person was granted 7,200 (400 post-split) RSUs, vesting on the first anniversary of the date of grant."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":400},"source":{"system":"sec-edgar","filing":"0001193125-26-343080","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000119312526343080/ownership.xml","form_type":"4"}},{"id":691889,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25019,"kind":"person","name":"Harsanyi Zsolt","position":1,"cik":"0001380184","reported_name":"Harsanyi Zsolt","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-08-11T01:39:05.000Z","date":"2026-08-06","kind":"exercise","planned":false,"acquired":true,"shares":400,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."}],"balance_after":400,"source":{"system":"sec-edgar","filing":"0001193125-26-343080","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000119312526343080/ownership.xml","form_type":"4"}},{"id":691888,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25018,"kind":"person","name":"Lamothe Jeffrey G.","position":1,"cik":"0001679967","reported_name":"Lamothe Jeffrey G.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Unit","published_at":"2026-08-11T01:38:03.000Z","date":"2026-08-06","kind":"exercise","planned":false,"acquired":false,"shares":961,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On August 6, 2025, the reporting person was granted 17,300 (961 post-split) RSUs, vesting on the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On August 6, 2025, the reporting person was granted 17,300 (961 post-split) RSUs, vesting on the first anniversary of the date of grant."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":961},"source":{"system":"sec-edgar","filing":"0001193125-26-343079","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000119312526343079/ownership.xml","form_type":"4"}},{"id":691887,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25018,"kind":"person","name":"Lamothe Jeffrey G.","position":1,"cik":"0001679967","reported_name":"Lamothe Jeffrey G.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-08-11T01:38:03.000Z","date":"2026-08-06","kind":"exercise","planned":false,"acquired":true,"shares":961,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."}],"balance_after":961,"source":{"system":"sec-edgar","filing":"0001193125-26-343079","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000119312526343079/ownership.xml","form_type":"4"}},{"id":691886,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25017,"kind":"person","name":"Taylor Daphne","position":1,"cik":"0001393549","reported_name":"Taylor Daphne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CFO"}}],"security":"Restricted Stock Unit","published_at":"2026-08-11T01:37:03.000Z","date":"2026-08-06","kind":"exercise","planned":false,"acquired":false,"shares":638,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On August 6, 2025, the reporting person was granted 11,500 (638 post-split) RSUs, vesting on the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On August 6, 2025, the reporting person was granted 11,500 (638 post-split) RSUs, vesting on the first anniversary of the date of grant."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":638},"source":{"system":"sec-edgar","filing":"0001193125-26-343077","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000119312526343077/ownership.xml","form_type":"4"}},{"id":691885,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25017,"kind":"person","name":"Taylor Daphne","position":1,"cik":"0001393549","reported_name":"Taylor Daphne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CFO"}}],"security":"Common Stock","published_at":"2026-08-11T01:37:03.000Z","date":"2026-08-06","kind":"exercise","planned":false,"acquired":true,"shares":638,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."}],"balance_after":638,"source":{"system":"sec-edgar","filing":"0001193125-26-343077","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000119312526343077/ownership.xml","form_type":"4"}},{"id":691996,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25060,"kind":"person","name":"Kwon SoYoung","position":1,"cik":"0001864406","reported_name":"Kwon SoYoung","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, GC, BD & Corp Affairs"}}],"security":"Restricted Stock Unit","published_at":"2026-08-11T01:36:04.000Z","date":"2026-08-06","kind":"exercise","planned":false,"acquired":false,"shares":638,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On August 6, 2025, the reporting person was granted 11,500 (638 post-split) RSUs, vesting on the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On August 6, 2025, the reporting person was granted 11,500 (638 post-split) RSUs, vesting on the first anniversary of the date of grant."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":638},"source":{"system":"sec-edgar","filing":"0001193125-26-343076","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1864406/000119312526343076/ownership.xml","form_type":"4"}},{"id":691995,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25060,"kind":"person","name":"Kwon SoYoung","position":1,"cik":"0001864406","reported_name":"Kwon SoYoung","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, GC, BD & Corp Affairs"}}],"security":"Common Stock","published_at":"2026-08-11T01:36:04.000Z","date":"2026-08-06","kind":"exercise","planned":false,"acquired":true,"shares":638,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."}],"balance_after":638,"source":{"system":"sec-edgar","filing":"0001193125-26-343076","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1864406/000119312526343076/ownership.xml","form_type":"4"}},{"id":691884,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25016,"kind":"person","name":"Huebner Dirk","position":1,"cik":"0001760345","reported_name":"Huebner Dirk","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CMO"}}],"security":"Restricted Stock Unit","published_at":"2026-08-11T01:35:04.000Z","date":"2026-08-06","kind":"exercise","planned":false,"acquired":false,"shares":638,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On August 6, 2025, the reporting person was granted 11,500 (638 post-split) RSUs, vesting on the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On August 6, 2025, the reporting person was granted 11,500 (638 post-split) RSUs, vesting on the first anniversary of the date of grant."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":638},"source":{"system":"sec-edgar","filing":"0001193125-26-343073","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000119312526343073/ownership.xml","form_type":"4"}},{"id":691883,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25016,"kind":"person","name":"Huebner Dirk","position":1,"cik":"0001760345","reported_name":"Huebner Dirk","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CMO"}}],"security":"Common Stock","published_at":"2026-08-11T01:35:04.000Z","date":"2026-08-06","kind":"tax_withholding","planned":false,"acquired":false,"shares":156,"price":4.07,"value":634.92,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents shares withheld by Issuer to satisfy tax withholding obligations on the vesting of RSUs."}],"balance_after":482,"source":{"system":"sec-edgar","filing":"0001193125-26-343073","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000119312526343073/ownership.xml","form_type":"4"}},{"id":691882,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25016,"kind":"person","name":"Huebner Dirk","position":1,"cik":"0001760345","reported_name":"Huebner Dirk","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CMO"}}],"security":"Common Stock","published_at":"2026-08-11T01:35:04.000Z","date":"2026-08-06","kind":"exercise","planned":false,"acquired":true,"shares":638,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."}],"balance_after":638,"source":{"system":"sec-edgar","filing":"0001193125-26-343073","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000119312526343073/ownership.xml","form_type":"4"}},{"id":691881,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25015,"kind":"person","name":"Grant Grady III","position":1,"cik":"0001679966","reported_name":"Grant Grady III","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2026-08-11T01:35:03.000Z","date":"2026-08-06","kind":"exercise","planned":false,"acquired":false,"shares":400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On August 6, 2025, the reporting person was granted 7,200 (400 post-split) RSUs, vesting on the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On August 6, 2025, the reporting person was granted 7,200 (400 post-split) RSUs, vesting on the first anniversary of the date of grant."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":400},"source":{"system":"sec-edgar","filing":"0001193125-26-343072","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000119312526343072/ownership.xml","form_type":"4"}},{"id":691880,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25015,"kind":"person","name":"Grant Grady III","position":1,"cik":"0001679966","reported_name":"Grant Grady III","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-08-11T01:35:03.000Z","date":"2026-08-06","kind":"exercise","planned":false,"acquired":true,"shares":400,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."}],"balance_after":1150,"source":{"system":"sec-edgar","filing":"0001193125-26-343072","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000119312526343072/ownership.xml","form_type":"4"}},{"id":691879,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25014,"kind":"person","name":"White Marvin L","position":1,"cik":"0001493324","reported_name":"White Marvin L","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chair"}}],"security":"Restricted Stock Unit","published_at":"2026-08-11T01:34:08.000Z","date":"2026-08-06","kind":"exercise","planned":false,"acquired":false,"shares":1666,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On August 6, 2025, the reporting person was granted 30,000 (1,666 post-split) RSUs, vesting on the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On August 6, 2025, the reporting person was granted 30,000 (1,666 post-split) RSUs, vesting on the first anniversary of the date of grant."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1666},"source":{"system":"sec-edgar","filing":"0001193125-26-343070","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000119312526343070/ownership.xml","form_type":"4"}},{"id":691878,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25014,"kind":"person","name":"White Marvin L","position":1,"cik":"0001493324","reported_name":"White Marvin L","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chair"}}],"security":"Restricted Stock Unit","published_at":"2026-08-11T01:34:08.000Z","date":"2026-07-17","kind":"exercise","planned":false,"acquired":false,"shares":1,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On July 17, 2024, the reporting person was granted 22,325 (1 post-splits) RSUs, vesting in three approximately equal annual installments beginning on July 17, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On July 17, 2024, the reporting person was granted 22,325 (1 post-splits) RSUs, vesting in three approximately equal annual installments beginning on July 17, 2025."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1},"source":{"system":"sec-edgar","filing":"0001193125-26-343070","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000119312526343070/ownership.xml","form_type":"4"}},{"id":691877,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25014,"kind":"person","name":"White Marvin L","position":1,"cik":"0001493324","reported_name":"White Marvin L","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chair"}}],"security":"Common Stock","published_at":"2026-08-11T01:34:08.000Z","date":"2026-08-06","kind":"tax_withholding","planned":false,"acquired":false,"shares":406,"price":4.07,"value":1652.42,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents shares withheld by Issuer to satisfy tax withholding obligations on the vesting of RSUs."}],"balance_after":1261,"source":{"system":"sec-edgar","filing":"0001193125-26-343070","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000119312526343070/ownership.xml","form_type":"4"}},{"id":691876,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25014,"kind":"person","name":"White Marvin L","position":1,"cik":"0001493324","reported_name":"White Marvin L","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chair"}}],"security":"Common Stock","published_at":"2026-08-11T01:34:08.000Z","date":"2026-08-06","kind":"exercise","planned":false,"acquired":true,"shares":1666,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."}],"balance_after":1667,"source":{"system":"sec-edgar","filing":"0001193125-26-343070","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000119312526343070/ownership.xml","form_type":"4"}},{"id":691875,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25014,"kind":"person","name":"White Marvin L","position":1,"cik":"0001493324","reported_name":"White Marvin L","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chair"}}],"security":"Common Stock","published_at":"2026-08-11T01:34:08.000Z","date":"2026-07-17","kind":"exercise","planned":false,"acquired":true,"shares":1,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."}],"balance_after":1,"source":{"system":"sec-edgar","filing":"0001193125-26-343070","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000119312526343070/ownership.xml","form_type":"4"}},{"id":691874,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25013,"kind":"person","name":"Abdun-Nabi Daniel","position":1,"cik":"0001380187","reported_name":"Abdun-Nabi Daniel","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2026-08-11T01:33:02.000Z","date":"2026-08-06","kind":"exercise","planned":false,"acquired":false,"shares":400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On August 6, 2025, the reporting person was granted 7,200 (400 post-split) RSUs, vesting on the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On August 6, 2025, the reporting person was granted 7,200 (400 post-split) RSUs, vesting on the first anniversary of the date of grant."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":400},"source":{"system":"sec-edgar","filing":"0001193125-26-343069","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000119312526343069/ownership.xml","form_type":"4"}},{"id":691873,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25013,"kind":"person","name":"Abdun-Nabi Daniel","position":1,"cik":"0001380187","reported_name":"Abdun-Nabi Daniel","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-08-11T01:33:02.000Z","date":"2026-08-06","kind":"exercise","planned":false,"acquired":true,"shares":400,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."}],"balance_after":400,"source":{"system":"sec-edgar","filing":"0001193125-26-343069","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000119312526343069/ownership.xml","form_type":"4"}},{"id":691872,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25012,"kind":"person","name":"Kunz Barbara Lopez","position":1,"cik":"0001679970","reported_name":"Kunz Barbara Lopez","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2026-08-11T01:32:03.000Z","date":"2026-08-06","kind":"exercise","planned":false,"acquired":false,"shares":400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On August 6, 2025, the reporting person was granted 7,200 (400 post-split) RSUs, vesting on the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On August 6, 2025, the reporting person was granted 7,200 (400 post-split) RSUs, vesting on the first anniversary of the date of grant."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":400},"source":{"system":"sec-edgar","filing":"0001193125-26-343067","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000119312526343067/ownership.xml","form_type":"4"}},{"id":691871,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25012,"kind":"person","name":"Kunz Barbara Lopez","position":1,"cik":"0001679970","reported_name":"Kunz Barbara Lopez","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-08-11T01:32:03.000Z","date":"2026-08-06","kind":"exercise","planned":false,"acquired":true,"shares":400,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."}],"balance_after":400,"source":{"system":"sec-edgar","filing":"0001193125-26-343067","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000119312526343067/ownership.xml","form_type":"4"}},{"id":691870,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25011,"kind":"person","name":"Niederhuber John","position":1,"cik":"0001501240","reported_name":"Niederhuber John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2026-08-11T01:30:07.000Z","date":"2026-08-06","kind":"exercise","planned":false,"acquired":false,"shares":400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On August 6, 2025, the reporting person was granted 7,200 (400 post-split) RSUs, vesting on the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On August 6, 2025, the reporting person was granted 7,200 (400 post-split) RSUs, vesting on the first anniversary of the date of grant."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":400},"source":{"system":"sec-edgar","filing":"0001193125-26-343065","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000119312526343065/ownership.xml","form_type":"4"}},{"id":691869,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25011,"kind":"person","name":"Niederhuber John","position":1,"cik":"0001501240","reported_name":"Niederhuber John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-08-11T01:30:07.000Z","date":"2026-08-06","kind":"exercise","planned":false,"acquired":true,"shares":400,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."}],"balance_after":400,"source":{"system":"sec-edgar","filing":"0001193125-26-343065","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000119312526343065/ownership.xml","form_type":"4"}},{"id":1002020,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25015,"kind":"person","name":"Grant Grady III","position":1,"cik":"0001679966","reported_name":"Grant Grady III","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-12T21:33:00.000Z","date":"2025-11-10","kind":"purchase","planned":false,"acquired":true,"shares":13513,"price":1.49,"value":20134.37,"ownership":{"direct":true},"balance_after":13514,"source":{"system":"sec-edgar","filing":"0001193125-25-277771","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000119312525277771/ownership.xml","form_type":"4"}},{"id":1071385,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25013,"kind":"person","name":"Abdun-Nabi Daniel","position":1,"cik":"0001380187","reported_name":"Abdun-Nabi Daniel","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2025-08-08T20:36:41.000Z","date":"2025-08-06","kind":"grant","planned":false,"acquired":true,"shares":7200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vest in full on the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vest in full on the first anniversary of the date of grant."}],"balance_after":7200,"derivative":{"underlying":"Common Stock","underlying_shares":7200},"source":{"system":"sec-edgar","filing":"0000950170-25-105942","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000095017025105942/ownership.xml","form_type":"4"}},{"id":1071384,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25017,"kind":"person","name":"Taylor Daphne","position":1,"cik":"0001393549","reported_name":"Taylor Daphne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CFO"}}],"security":"Restricted Stock Unit","published_at":"2025-08-08T20:35:41.000Z","date":"2025-08-06","kind":"grant","planned":false,"acquired":true,"shares":11500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vest in full on the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vest in full on the first anniversary of the date of grant."}],"balance_after":11500,"derivative":{"underlying":"Common Stock","underlying_shares":11500},"source":{"system":"sec-edgar","filing":"0000950170-25-105938","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000095017025105938/ownership.xml","form_type":"4"}},{"id":1071383,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25015,"kind":"person","name":"Grant Grady III","position":1,"cik":"0001679966","reported_name":"Grant Grady III","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2025-08-08T20:34:57.000Z","date":"2025-08-06","kind":"grant","planned":false,"acquired":true,"shares":7200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vest in full on the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vest in full on the first anniversary of the date of grant."}],"balance_after":7200,"derivative":{"underlying":"Common Stock","underlying_shares":7200},"source":{"system":"sec-edgar","filing":"0000950170-25-105936","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000095017025105936/ownership.xml","form_type":"4"}},{"id":1071381,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25016,"kind":"person","name":"Huebner Dirk","position":1,"cik":"0001760345","reported_name":"Huebner Dirk","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CMO"}}],"security":"Restricted Stock Unit","published_at":"2025-08-08T20:34:23.000Z","date":"2025-08-06","kind":"grant","planned":false,"acquired":true,"shares":11500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vest in full on the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vest in full on the first anniversary of the date of grant."}],"balance_after":11500,"derivative":{"underlying":"Common Stock","underlying_shares":11500},"source":{"system":"sec-edgar","filing":"0000950170-25-105935","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000095017025105935/ownership.xml","form_type":"4"}},{"id":1071382,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25011,"kind":"person","name":"Niederhuber John","position":1,"cik":"0001501240","reported_name":"Niederhuber John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2025-08-08T20:33:35.000Z","date":"2025-08-06","kind":"grant","planned":false,"acquired":true,"shares":7200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vest in full on the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vest in full on the first anniversary of the date of grant."}],"balance_after":7200,"derivative":{"underlying":"Common Stock","underlying_shares":7200},"source":{"system":"sec-edgar","filing":"0000950170-25-105933","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000095017025105933/ownership.xml","form_type":"4"}},{"id":1071380,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25018,"kind":"person","name":"Lamothe Jeffrey G.","position":1,"cik":"0001679967","reported_name":"Lamothe Jeffrey G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, COO"}}],"security":"Restricted Stock Unit","published_at":"2025-08-08T20:32:57.000Z","date":"2025-08-06","kind":"grant","planned":false,"acquired":true,"shares":17300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vest in full on the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vest in full on the first anniversary of the date of grant."}],"balance_after":17300,"derivative":{"underlying":"Common Stock","underlying_shares":17300},"source":{"system":"sec-edgar","filing":"0000950170-25-105930","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000095017025105930/ownership.xml","form_type":"4"}},{"id":1071379,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25014,"kind":"person","name":"White Marvin L","position":1,"cik":"0001493324","reported_name":"White Marvin L","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Unit","published_at":"2025-08-08T20:31:44.000Z","date":"2025-08-06","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vest in full on the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vest in full on the first anniversary of the date of grant."}],"balance_after":30000,"derivative":{"underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0000950170-25-105922","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000095017025105922/ownership.xml","form_type":"4"}},{"id":1071377,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25012,"kind":"person","name":"Kunz Barbara Lopez","position":1,"cik":"0001679970","reported_name":"Kunz Barbara Lopez","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2025-08-08T20:31:19.000Z","date":"2025-08-06","kind":"grant","planned":false,"acquired":true,"shares":7200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vest in full on the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vest in full on the first anniversary of the date of grant."}],"balance_after":7200,"derivative":{"underlying":"Common Stock","underlying_shares":7200},"source":{"system":"sec-edgar","filing":"0000950170-25-105919","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000095017025105919/ownership.xml","form_type":"4"}},{"id":1071450,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25060,"kind":"person","name":"Kwon SoYoung","position":1,"cik":"0001864406","reported_name":"Kwon SoYoung","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, GC, BD & Corp Affairs"}}],"security":"Restricted Stock Unit","published_at":"2025-08-08T20:29:09.000Z","date":"2025-08-06","kind":"grant","planned":false,"acquired":true,"shares":11500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vest in full on the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vest in full on the first anniversary of the date of grant."}],"balance_after":11500,"derivative":{"underlying":"Common Stock","underlying_shares":11500},"source":{"system":"sec-edgar","filing":"0000950170-25-105894","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1864406/000095017025105894/ownership.xml","form_type":"4"}},{"id":1071378,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25019,"kind":"person","name":"Harsanyi Zsolt","position":1,"cik":"0001380184","reported_name":"Harsanyi Zsolt","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2025-08-08T20:27:30.000Z","date":"2025-08-06","kind":"grant","planned":false,"acquired":true,"shares":7200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vest in full on the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vest in full on the first anniversary of the date of grant."}],"balance_after":7200,"derivative":{"underlying":"Common Stock","underlying_shares":7200},"source":{"system":"sec-edgar","filing":"0000950170-25-105887","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000095017025105887/ownership.xml","form_type":"4"}},{"id":1084041,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25019,"kind":"person","name":"Harsanyi Zsolt","position":1,"cik":"0001380184","reported_name":"Harsanyi Zsolt","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2025-07-21T20:43:57.000Z","date":"2025-07-17","kind":"exercise","planned":false,"acquired":false,"shares":1,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On July 17, 2024, the reporting person was granted 925 (1 post-splits) RSUs, vesting in full one year from the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On July 17, 2024, the reporting person was granted 925 (1 post-splits) RSUs, vesting in full one year from the date of grant."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1},"source":{"system":"sec-edgar","filing":"0000950170-25-097283","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000095017025097283/ownership.xml","form_type":"4"}},{"id":1084040,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25019,"kind":"person","name":"Harsanyi Zsolt","position":1,"cik":"0001380184","reported_name":"Harsanyi Zsolt","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-07-21T20:43:57.000Z","date":"2025-07-17","kind":"exercise","planned":false,"acquired":true,"shares":1,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."}],"balance_after":1,"source":{"system":"sec-edgar","filing":"0000950170-25-097283","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000095017025097283/ownership.xml","form_type":"4"}},{"id":1084039,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25012,"kind":"person","name":"Kunz Barbara Lopez","position":1,"cik":"0001679970","reported_name":"Kunz Barbara Lopez","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2025-07-21T20:42:49.000Z","date":"2025-07-17","kind":"exercise","planned":false,"acquired":false,"shares":1,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On July 17, 2024, the reporting person was granted 925 (1 post-splits) RSUs, vesting in full one year from the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On July 17, 2024, the reporting person was granted 925 (1 post-splits) RSUs, vesting in full one year from the date of grant."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1},"source":{"system":"sec-edgar","filing":"0000950170-25-097280","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000095017025097280/ownership.xml","form_type":"4"}},{"id":1084038,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25012,"kind":"person","name":"Kunz Barbara Lopez","position":1,"cik":"0001679970","reported_name":"Kunz Barbara Lopez","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-07-21T20:42:49.000Z","date":"2025-07-17","kind":"exercise","planned":false,"acquired":true,"shares":1,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."}],"balance_after":1,"source":{"system":"sec-edgar","filing":"0000950170-25-097280","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000095017025097280/ownership.xml","form_type":"4"}},{"id":1084037,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25013,"kind":"person","name":"Abdun-Nabi Daniel","position":1,"cik":"0001380187","reported_name":"Abdun-Nabi Daniel","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2025-07-21T20:41:34.000Z","date":"2025-07-17","kind":"exercise","planned":false,"acquired":false,"shares":1,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On July 17, 2024, the reporting person was granted 925 (1 post-splits) RSUs, vesting in full one year from the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On July 17, 2024, the reporting person was granted 925 (1 post-splits) RSUs, vesting in full one year from the date of grant."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1},"source":{"system":"sec-edgar","filing":"0000950170-25-097279","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000095017025097279/ownership.xml","form_type":"4"}},{"id":1084036,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25013,"kind":"person","name":"Abdun-Nabi Daniel","position":1,"cik":"0001380187","reported_name":"Abdun-Nabi Daniel","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-07-21T20:41:34.000Z","date":"2025-07-17","kind":"exercise","planned":false,"acquired":true,"shares":1,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."}],"balance_after":1,"source":{"system":"sec-edgar","filing":"0000950170-25-097279","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000095017025097279/ownership.xml","form_type":"4"}},{"id":1084035,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25015,"kind":"person","name":"Grant Grady III","position":1,"cik":"0001679966","reported_name":"Grant Grady III","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2025-07-21T20:40:38.000Z","date":"2025-07-17","kind":"exercise","planned":false,"acquired":false,"shares":1,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On July 17, 2024, the reporting person was granted 925 (1 post-splits) RSUs, vesting in full one year from the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On July 17, 2024, the reporting person was granted 925 (1 post-splits) RSUs, vesting in full one year from the date of grant."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1},"source":{"system":"sec-edgar","filing":"0000950170-25-097278","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000095017025097278/ownership.xml","form_type":"4"}},{"id":1084034,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25015,"kind":"person","name":"Grant Grady III","position":1,"cik":"0001679966","reported_name":"Grant Grady III","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-07-21T20:40:38.000Z","date":"2025-07-17","kind":"exercise","planned":false,"acquired":true,"shares":1,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."}],"balance_after":1,"source":{"system":"sec-edgar","filing":"0000950170-25-097278","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000095017025097278/ownership.xml","form_type":"4"}},{"id":1084031,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25011,"kind":"person","name":"Niederhuber John","position":1,"cik":"0001501240","reported_name":"Niederhuber John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2025-07-21T20:39:30.000Z","date":"2025-07-17","kind":"exercise","planned":false,"acquired":false,"shares":1,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On July 17, 2024, the reporting person was granted 925 (1 post-splits) RSUs, vesting in full one year from the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On July 17, 2024, the reporting person was granted 925 (1 post-splits) RSUs, vesting in full one year from the date of grant."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1},"source":{"system":"sec-edgar","filing":"0000950170-25-097274","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000095017025097274/ownership.xml","form_type":"4"}},{"id":1084030,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25011,"kind":"person","name":"Niederhuber John","position":1,"cik":"0001501240","reported_name":"Niederhuber John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-07-21T20:39:30.000Z","date":"2025-07-17","kind":"exercise","planned":false,"acquired":true,"shares":1,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."}],"balance_after":1,"source":{"system":"sec-edgar","filing":"0000950170-25-097274","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000095017025097274/ownership.xml","form_type":"4"}},{"id":1084033,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25017,"kind":"person","name":"Taylor Daphne","position":1,"cik":"0001393549","reported_name":"Taylor Daphne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CFO"}}],"security":"Restricted Stock Unit","published_at":"2025-07-21T20:38:27.000Z","date":"2025-07-17","kind":"exercise","planned":false,"acquired":false,"shares":3,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On July 17, 2024, the reporting person was granted 8,550 (11 post-splits) RSUs, vesting in three approximately equal annual installments beginning on July 17, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On July 17, 2024, the reporting person was granted 8,550 (11 post-splits) RSUs, vesting in three approximately equal annual installments beginning on July 17, 2025."}],"balance_after":8,"derivative":{"underlying":"Common Stock","underlying_shares":11},"source":{"system":"sec-edgar","filing":"0000950170-25-097272","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000095017025097272/ownership.xml","form_type":"4"}},{"id":1084032,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25017,"kind":"person","name":"Taylor Daphne","position":1,"cik":"0001393549","reported_name":"Taylor Daphne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CFO"}}],"security":"Common Stock","published_at":"2025-07-21T20:38:27.000Z","date":"2025-07-17","kind":"exercise","planned":false,"acquired":true,"shares":3,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."}],"balance_after":3,"source":{"system":"sec-edgar","filing":"0000950170-25-097272","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000095017025097272/ownership.xml","form_type":"4"}},{"id":1084113,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25060,"kind":"person","name":"Kwon SoYoung","position":1,"cik":"0001864406","reported_name":"Kwon SoYoung","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, GC, BD & Corp Affairs"}}],"security":"Restricted Stock Unit","published_at":"2025-07-21T20:37:27.000Z","date":"2025-07-17","kind":"exercise","planned":false,"acquired":false,"shares":3,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On July 17, 2024, the reporting person was granted 8,550 (11 post-splits) RSUs, vesting in three approximately equal annual installments beginning on July 17, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On July 17, 2024, the reporting person was granted 8,550 (11 post-splits) RSUs, vesting in three approximately equal annual installments beginning on July 17, 2025."}],"balance_after":8,"derivative":{"underlying":"Common Stock","underlying_shares":11},"source":{"system":"sec-edgar","filing":"0000950170-25-097271","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1864406/000095017025097271/ownership.xml","form_type":"4"}},{"id":1084112,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25060,"kind":"person","name":"Kwon SoYoung","position":1,"cik":"0001864406","reported_name":"Kwon SoYoung","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, GC, BD & Corp Affairs"}}],"security":"Common Stock","published_at":"2025-07-21T20:37:27.000Z","date":"2025-07-17","kind":"exercise","planned":false,"acquired":true,"shares":3,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."}],"balance_after":4,"source":{"system":"sec-edgar","filing":"0000950170-25-097271","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1864406/000095017025097271/ownership.xml","form_type":"4"}},{"id":1084029,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25014,"kind":"person","name":"White Marvin L","position":1,"cik":"0001493324","reported_name":"White Marvin L","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Unit","published_at":"2025-07-21T20:36:20.000Z","date":"2025-07-17","kind":"exercise","planned":false,"acquired":false,"shares":10,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On July 17, 2024, the reporting person was granted 22,325 (30 post-splits) RSUs, vesting in three approximately equal annual installments beginning on July 17, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On July 17, 2024, the reporting person was granted 22,325 (30 post-splits) RSUs, vesting in three approximately equal annual installments beginning on July 17, 2025."}],"balance_after":20,"derivative":{"underlying":"Common Stock","underlying_shares":30},"source":{"system":"sec-edgar","filing":"0000950170-25-097269","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000095017025097269/ownership.xml","form_type":"4"}},{"id":1084028,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25014,"kind":"person","name":"White Marvin L","position":1,"cik":"0001493324","reported_name":"White Marvin L","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-07-21T20:36:20.000Z","date":"2025-07-17","kind":"exercise","planned":false,"acquired":true,"shares":10,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."}],"balance_after":12,"source":{"system":"sec-edgar","filing":"0000950170-25-097269","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000095017025097269/ownership.xml","form_type":"4"}},{"id":1084027,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25018,"kind":"person","name":"Lamothe Jeffrey G.","position":1,"cik":"0001679967","reported_name":"Lamothe Jeffrey G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, COO"}}],"security":"Restricted Stock Unit","published_at":"2025-07-21T20:35:23.000Z","date":"2025-07-17","kind":"exercise","planned":false,"acquired":false,"shares":5,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On July 17, 2024, the reporting person was granted 12,825 (17 post-splits) RSUs, vesting in three approximately equal annual installments beginning on July 17, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On July 17, 2024, the reporting person was granted 12,825 (17 post-splits) RSUs, vesting in three approximately equal annual installments beginning on July 17, 2025."}],"balance_after":12,"derivative":{"underlying":"Common Stock","underlying_shares":17},"source":{"system":"sec-edgar","filing":"0000950170-25-097267","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000095017025097267/ownership.xml","form_type":"4"}},{"id":1084026,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25018,"kind":"person","name":"Lamothe Jeffrey G.","position":1,"cik":"0001679967","reported_name":"Lamothe Jeffrey G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, COO"}}],"security":"Common Stock (post-reverse split May ACTIVE)","published_at":"2025-07-21T20:35:23.000Z","date":"2025-07-17","kind":"exercise","planned":false,"acquired":true,"shares":5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."}],"balance_after":6,"source":{"system":"sec-edgar","filing":"0000950170-25-097267","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000095017025097267/ownership.xml","form_type":"4"}},{"id":1229400,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25060,"kind":"person","name":"Kwon SoYoung","position":1,"cik":"0001864406","reported_name":"Kwon SoYoung","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, GC, BD & Corp Affairs"}}],"security":"Restricted Stock Unit","published_at":"2025-03-04T21:36:04.000Z","date":"2025-03-03","kind":"exercise","planned":false,"acquired":false,"shares":2,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On June 7, 2022, the reporting person was granted 11,000 (7 post-splits) RSUs, vesting in three approximately equal annual installments beginning on March 3, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On June 7, 2022, the reporting person was granted 11,000 (7 post-splits) RSUs, vesting in three approximately equal annual installments beginning on March 3, 2023."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":2},"source":{"system":"sec-edgar","filing":"0000950170-25-032201","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1864406/000095017025032201/ownership.xml","form_type":"4"}},{"id":1229399,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25060,"kind":"person","name":"Kwon SoYoung","position":1,"cik":"0001864406","reported_name":"Kwon SoYoung","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, GC, BD & Corp Affairs"}}],"security":"Restricted Stock Unit","published_at":"2025-03-04T21:36:04.000Z","date":"2025-03-02","kind":"exercise","planned":false,"acquired":false,"shares":2,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On March 3, 2023, the reporting person was granted 11,000 (7 post-splits) RSUs, vesting in three approximately equal annual installments beginning on March 2, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On March 3, 2023, the reporting person was granted 11,000 (7 post-splits) RSUs, vesting in three approximately equal annual installments beginning on March 2, 2024."}],"balance_after":2,"derivative":{"underlying":"Common Stock","underlying_shares":2},"source":{"system":"sec-edgar","filing":"0000950170-25-032201","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1864406/000095017025032201/ownership.xml","form_type":"4"}},{"id":1229398,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25060,"kind":"person","name":"Kwon SoYoung","position":1,"cik":"0001864406","reported_name":"Kwon SoYoung","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, GC, BD & Corp Affairs"}}],"security":"Common Stock","published_at":"2025-03-04T21:36:04.000Z","date":"2025-03-03","kind":"exercise","planned":false,"acquired":true,"shares":2,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."}],"balance_after":25,"source":{"system":"sec-edgar","filing":"0000950170-25-032201","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1864406/000095017025032201/ownership.xml","form_type":"4"}},{"id":1229397,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25060,"kind":"person","name":"Kwon SoYoung","position":1,"cik":"0001864406","reported_name":"Kwon SoYoung","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, GC, BD & Corp Affairs"}}],"security":"Common Stock","published_at":"2025-03-04T21:36:04.000Z","date":"2025-03-02","kind":"exercise","planned":false,"acquired":true,"shares":2,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."}],"balance_after":23,"source":{"system":"sec-edgar","filing":"0000950170-25-032201","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1864406/000095017025032201/ownership.xml","form_type":"4"}},{"id":1228502,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25018,"kind":"person","name":"Lamothe Jeffrey G.","position":1,"cik":"0001679967","reported_name":"Lamothe Jeffrey G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, COO"}}],"security":"Restricted Stock Unit","published_at":"2025-03-04T21:35:19.000Z","date":"2025-03-03","kind":"exercise","planned":false,"acquired":false,"shares":2,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On June 7, 2022, the reporting person was granted 11,000 (7 post-splits) RSUs, vesting in three approximately equal annual installments beginning on March 3, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On June 7, 2022, the reporting person was granted 11,000 (7 post-splits) RSUs, vesting in three approximately equal annual installments beginning on March 3, 2023."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":2},"source":{"system":"sec-edgar","filing":"0000950170-25-032197","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000095017025032197/ownership.xml","form_type":"4"}},{"id":1228501,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25018,"kind":"person","name":"Lamothe Jeffrey G.","position":1,"cik":"0001679967","reported_name":"Lamothe Jeffrey G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, COO"}}],"security":"Restricted Stock Unit","published_at":"2025-03-04T21:35:19.000Z","date":"2025-03-02","kind":"exercise","planned":false,"acquired":false,"shares":3,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On March 3, 2023, the reporting person was granted 16,500 (11 post-splits) RSUs, vesting in three approximately equal annual installments beginning on March 2, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On March 3, 2023, the reporting person was granted 16,500 (11 post-splits) RSUs, vesting in three approximately equal annual installments beginning on March 2, 2024."}],"balance_after":4,"derivative":{"underlying":"Common Stock","underlying_shares":3},"source":{"system":"sec-edgar","filing":"0000950170-25-032197","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000095017025032197/ownership.xml","form_type":"4"}},{"id":1228500,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25018,"kind":"person","name":"Lamothe Jeffrey G.","position":1,"cik":"0001679967","reported_name":"Lamothe Jeffrey G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, COO"}}],"security":"Common Stock","published_at":"2025-03-04T21:35:19.000Z","date":"2025-03-03","kind":"exercise","planned":false,"acquired":true,"shares":2,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."}],"balance_after":36,"source":{"system":"sec-edgar","filing":"0000950170-25-032197","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000095017025032197/ownership.xml","form_type":"4"}},{"id":1228499,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25018,"kind":"person","name":"Lamothe Jeffrey G.","position":1,"cik":"0001679967","reported_name":"Lamothe Jeffrey G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, COO"}}],"security":"Common Stock","published_at":"2025-03-04T21:35:19.000Z","date":"2025-03-02","kind":"exercise","planned":false,"acquired":true,"shares":3,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."}],"balance_after":34,"source":{"system":"sec-edgar","filing":"0000950170-25-032197","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000095017025032197/ownership.xml","form_type":"4"}},{"id":1228498,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25014,"kind":"person","name":"White Marvin L","position":1,"cik":"0001493324","reported_name":"White Marvin L","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Unit","published_at":"2025-03-04T21:33:33.000Z","date":"2025-03-03","kind":"exercise","planned":false,"acquired":false,"shares":6,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On June 7, 2022, the reporting person was granted 28,750 (18 post-splits) RSUs, vesting in three approximately equal annual installments beginning on March 3, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On June 7, 2022, the reporting person was granted 28,750 (18 post-splits) RSUs, vesting in three approximately equal annual installments beginning on March 3, 2023."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":6},"source":{"system":"sec-edgar","filing":"0000950170-25-032187","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000095017025032187/ownership.xml","form_type":"4"}},{"id":1228497,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25014,"kind":"person","name":"White Marvin L","position":1,"cik":"0001493324","reported_name":"White Marvin L","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Unit","published_at":"2025-03-04T21:33:33.000Z","date":"2025-03-02","kind":"exercise","planned":false,"acquired":false,"shares":8,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On March 3, 2023, the reporting person was granted 38,750 (24 post-splits) RSUs, vesting in three approximately equal annual installments beginning on March 2, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On March 3, 2023, the reporting person was granted 38,750 (24 post-splits) RSUs, vesting in three approximately equal annual installments beginning on March 2, 2024."}],"balance_after":8,"derivative":{"underlying":"Common Stock","underlying_shares":8},"source":{"system":"sec-edgar","filing":"0000950170-25-032187","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000095017025032187/ownership.xml","form_type":"4"}},{"id":1228496,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25014,"kind":"person","name":"White Marvin L","position":1,"cik":"0001493324","reported_name":"White Marvin L","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-03-04T21:33:33.000Z","date":"2025-03-03","kind":"exercise","planned":false,"acquired":true,"shares":6,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."}],"balance_after":55,"source":{"system":"sec-edgar","filing":"0000950170-25-032187","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000095017025032187/ownership.xml","form_type":"4"}},{"id":1228495,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25014,"kind":"person","name":"White Marvin L","position":1,"cik":"0001493324","reported_name":"White Marvin L","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-03-04T21:33:33.000Z","date":"2025-03-02","kind":"exercise","planned":false,"acquired":true,"shares":8,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."}],"balance_after":49,"source":{"system":"sec-edgar","filing":"0000950170-25-032187","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000095017025032187/ownership.xml","form_type":"4"}},{"id":1228494,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25017,"kind":"person","name":"Taylor Daphne","position":1,"cik":"0001393549","reported_name":"Taylor Daphne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CFO"}}],"security":"Restricted Stock Unit","published_at":"2025-03-04T21:32:32.000Z","date":"2025-03-04","kind":"exercise","planned":false,"acquired":false,"shares":1,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On June 7, 2022, the reporting person was granted 4,750 (3 post-splits) RSUs, vesting in three approximately equal annual installments beginning on March 4, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On June 7, 2022, the reporting person was granted 4,750 (3 post-splits) RSUs, vesting in three approximately equal annual installments beginning on March 4, 2023."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1},"source":{"system":"sec-edgar","filing":"0000950170-25-032183","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000095017025032183/ownership.xml","form_type":"4"}},{"id":1228493,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25017,"kind":"person","name":"Taylor Daphne","position":1,"cik":"0001393549","reported_name":"Taylor Daphne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CFO"}}],"security":"Restricted Stock Unit","published_at":"2025-03-04T21:32:32.000Z","date":"2025-03-02","kind":"exercise","planned":false,"acquired":false,"shares":2,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On March 3, 2023, the reporting person was granted 11,000 (7 post-splits) RSUs, vesting in three approximately equal annual installments beginning on March 2, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On March 3, 2023, the reporting person was granted 11,000 (7 post-splits) RSUs, vesting in three approximately equal annual installments beginning on March 2, 2024."}],"balance_after":2,"derivative":{"underlying":"Common Stock","underlying_shares":2},"source":{"system":"sec-edgar","filing":"0000950170-25-032183","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000095017025032183/ownership.xml","form_type":"4"}},{"id":1228492,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25017,"kind":"person","name":"Taylor Daphne","position":1,"cik":"0001393549","reported_name":"Taylor Daphne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CFO"}}],"security":"Common Stock","published_at":"2025-03-04T21:32:32.000Z","date":"2025-03-04","kind":"exercise","planned":false,"acquired":true,"shares":1,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."}],"balance_after":18,"source":{"system":"sec-edgar","filing":"0000950170-25-032183","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000095017025032183/ownership.xml","form_type":"4"}},{"id":1228491,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25017,"kind":"person","name":"Taylor Daphne","position":1,"cik":"0001393549","reported_name":"Taylor Daphne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CFO"}}],"security":"Common Stock","published_at":"2025-03-04T21:32:32.000Z","date":"2025-03-02","kind":"exercise","planned":false,"acquired":true,"shares":2,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."}],"balance_after":17,"source":{"system":"sec-edgar","filing":"0000950170-25-032183","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000095017025032183/ownership.xml","form_type":"4"}},{"id":1437007,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25060,"kind":"person","name":"Kwon SoYoung","position":1,"cik":"0001864406","reported_name":"Kwon SoYoung","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, GC, BD & Corp Affairs"}}],"security":"Restricted Stock Unit","published_at":"2024-08-09T20:35:14.000Z","date":"2024-08-08","kind":"exercise","planned":false,"acquired":false,"shares":213,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On August 9, 2022, the reporting person was granted 18,750 (426 post-split) RSUs, vesting in two approximately equal annual installments beginning on August 8, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On August 9, 2022, the reporting person was granted 18,750 (426 post-split) RSUs, vesting in two approximately equal annual installments beginning on August 8, 2023."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":213},"source":{"system":"sec-edgar","filing":"0000950170-24-094819","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1864406/000095017024094819/ownership.xml","form_type":"4"}},{"id":1437006,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25060,"kind":"person","name":"Kwon SoYoung","position":1,"cik":"0001864406","reported_name":"Kwon SoYoung","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, GC, BD & Corp Affairs"}}],"security":"Common Stock","published_at":"2024-08-09T20:35:14.000Z","date":"2024-08-08","kind":"exercise","planned":false,"acquired":true,"shares":213,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."}],"balance_after":801,"source":{"system":"sec-edgar","filing":"0000950170-24-094819","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1864406/000095017024094819/ownership.xml","form_type":"4"}},{"id":1436928,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25018,"kind":"person","name":"Lamothe Jeffrey G.","position":1,"cik":"0001679967","reported_name":"Lamothe Jeffrey G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, COO"}}],"security":"Restricted Stock Unit","published_at":"2024-08-09T20:33:05.000Z","date":"2024-08-08","kind":"exercise","planned":false,"acquired":false,"shares":272,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On August 9, 2022, the reporting person was granted 23,958 (544 post-split) RSUs, vesting in two approximately equal annual installments beginning on August 8, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On August 9, 2022, the reporting person was granted 23,958 (544 post-split) RSUs, vesting in two approximately equal annual installments beginning on August 8, 2023."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":272},"source":{"system":"sec-edgar","filing":"0000950170-24-094816","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000095017024094816/ownership.xml","form_type":"4"}},{"id":1436927,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25018,"kind":"person","name":"Lamothe Jeffrey G.","position":1,"cik":"0001679967","reported_name":"Lamothe Jeffrey G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, COO"}}],"security":"Restricted Stock Unit","published_at":"2024-08-09T20:33:05.000Z","date":"2024-08-08","kind":"exercise","planned":false,"acquired":false,"shares":42,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On August 9, 2022, the reporting person was granted 5,500 (125 post-split) RSUs, vesting in three approximately equal annual installments beginning on August 8, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On August 9, 2022, the reporting person was granted 5,500 (125 post-split) RSUs, vesting in three approximately equal annual installments beginning on August 8, 2023."}],"balance_after":41,"derivative":{"underlying":"Common Stock","underlying_shares":42},"source":{"system":"sec-edgar","filing":"0000950170-24-094816","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000095017024094816/ownership.xml","form_type":"4"}},{"id":1436926,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25018,"kind":"person","name":"Lamothe Jeffrey G.","position":1,"cik":"0001679967","reported_name":"Lamothe Jeffrey G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, COO"}}],"security":"Common Stock","published_at":"2024-08-09T20:33:05.000Z","date":"2024-08-08","kind":"exercise","planned":false,"acquired":true,"shares":272,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."}],"balance_after":1166,"source":{"system":"sec-edgar","filing":"0000950170-24-094816","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000095017024094816/ownership.xml","form_type":"4"}},{"id":1436925,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25018,"kind":"person","name":"Lamothe Jeffrey G.","position":1,"cik":"0001679967","reported_name":"Lamothe Jeffrey G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, COO"}}],"security":"Common Stock","published_at":"2024-08-09T20:33:05.000Z","date":"2024-08-08","kind":"exercise","planned":false,"acquired":true,"shares":42,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."}],"balance_after":894,"source":{"system":"sec-edgar","filing":"0000950170-24-094816","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000095017024094816/ownership.xml","form_type":"4"}},{"id":1436924,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25017,"kind":"person","name":"Taylor Daphne","position":1,"cik":"0001393549","reported_name":"Taylor Daphne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CFO"}}],"security":"Restricted Stock Unit","published_at":"2024-08-09T20:30:57.000Z","date":"2024-08-08","kind":"exercise","planned":false,"acquired":false,"shares":158,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On August 9, 2022, the reporting person was granted 13,889 (315 post-split) RSUs, vesting in two approximately equal annual installments beginning on August 8, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On August 9, 2022, the reporting person was granted 13,889 (315 post-split) RSUs, vesting in two approximately equal annual installments beginning on August 8, 2023."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":158},"source":{"system":"sec-edgar","filing":"0000950170-24-094813","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000095017024094813/ownership.xml","form_type":"4"}},{"id":1436923,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25017,"kind":"person","name":"Taylor Daphne","position":1,"cik":"0001393549","reported_name":"Taylor Daphne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CFO"}}],"security":"Common Stock","published_at":"2024-08-09T20:30:57.000Z","date":"2024-08-08","kind":"exercise","planned":false,"acquired":true,"shares":158,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."}],"balance_after":576,"source":{"system":"sec-edgar","filing":"0000950170-24-094813","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000095017024094813/ownership.xml","form_type":"4"}},{"id":1451204,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25019,"kind":"person","name":"Harsanyi Zsolt","position":1,"cik":"0001380184","reported_name":"Harsanyi Zsolt","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2024-07-19T20:38:17.000Z","date":"2024-07-17","kind":"grant","planned":false,"acquired":true,"shares":925,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vest in full on the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vest in full on the first anniversary of the date of grant."}],"balance_after":925,"derivative":{"underlying":"Common Stock","underlying_shares":925},"source":{"system":"sec-edgar","filing":"0000950170-24-084958","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000095017024084958/ownership.xml","form_type":"4"}},{"id":1451203,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25017,"kind":"person","name":"Taylor Daphne","position":1,"cik":"0001393549","reported_name":"Taylor Daphne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CFO"}}],"security":"Restricted Stock Unit","published_at":"2024-07-19T20:37:25.000Z","date":"2024-07-17","kind":"grant","planned":false,"acquired":true,"shares":8550,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vest in three approximately equal annual installments beginning on July 17, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vest in three approximately equal annual installments beginning on July 17, 2025."}],"balance_after":8550,"derivative":{"underlying":"Common Stock","underlying_shares":8550},"source":{"system":"sec-edgar","filing":"0000950170-24-084955","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000095017024084955/ownership.xml","form_type":"4"}},{"id":1451202,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25015,"kind":"person","name":"Grant Grady III","position":1,"cik":"0001679966","reported_name":"Grant Grady III","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2024-07-19T20:36:40.000Z","date":"2024-07-17","kind":"grant","planned":false,"acquired":true,"shares":925,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vest in full on the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vest in full on the first anniversary of the date of grant."}],"balance_after":925,"derivative":{"underlying":"Common Stock","underlying_shares":925},"source":{"system":"sec-edgar","filing":"0000950170-24-084954","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000095017024084954/ownership.xml","form_type":"4"}},{"id":1451271,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25060,"kind":"person","name":"Kwon SoYoung","position":1,"cik":"0001864406","reported_name":"Kwon SoYoung","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, GC, BD & Corp Affairs"}}],"security":"Restricted Stock Unit","published_at":"2024-07-19T20:35:59.000Z","date":"2024-07-17","kind":"grant","planned":false,"acquired":true,"shares":8550,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vest in three approximately equal annual installments beginning on July 17, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vest in three approximately equal annual installments beginning on July 17, 2025."}],"balance_after":8550,"derivative":{"underlying":"Common Stock","underlying_shares":8550},"source":{"system":"sec-edgar","filing":"0000950170-24-084953","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1864406/000095017024084953/ownership.xml","form_type":"4"}},{"id":1451201,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25018,"kind":"person","name":"Lamothe Jeffrey G.","position":1,"cik":"0001679967","reported_name":"Lamothe Jeffrey G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, COO"}}],"security":"Restricted Stock Unit","published_at":"2024-07-19T20:35:11.000Z","date":"2024-07-17","kind":"grant","planned":false,"acquired":true,"shares":12825,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vest in three approximately equal annual installments beginning on July 17, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vest in three approximately equal annual installments beginning on July 17, 2025."}],"balance_after":12825,"derivative":{"underlying":"Common Stock","underlying_shares":12825},"source":{"system":"sec-edgar","filing":"0000950170-24-084952","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000095017024084952/ownership.xml","form_type":"4"}},{"id":1451200,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25014,"kind":"person","name":"White Marvin L","position":1,"cik":"0001493324","reported_name":"White Marvin L","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Unit","published_at":"2024-07-19T20:34:26.000Z","date":"2024-07-17","kind":"grant","planned":false,"acquired":true,"shares":22325,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vest in three approximately equal annual installments beginning on June 17, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vest in three approximately equal annual installments beginning on June 17, 2025."}],"balance_after":22325,"derivative":{"underlying":"Common Stock","underlying_shares":22325},"source":{"system":"sec-edgar","filing":"0000950170-24-084950","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000095017024084950/ownership.xml","form_type":"4"}},{"id":1451199,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25011,"kind":"person","name":"Niederhuber John","position":1,"cik":"0001501240","reported_name":"Niederhuber John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2024-07-19T20:32:58.000Z","date":"2024-07-17","kind":"grant","planned":false,"acquired":true,"shares":925,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vest in full on the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vest in full on the first anniversary of the date of grant."}],"balance_after":925,"derivative":{"underlying":"Common Stock","underlying_shares":925},"source":{"system":"sec-edgar","filing":"0000950170-24-084947","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000095017024084947/ownership.xml","form_type":"4"}},{"id":1451198,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25012,"kind":"person","name":"Kunz Barbara Lopez","position":1,"cik":"0001679970","reported_name":"Kunz Barbara Lopez","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2024-07-19T20:31:30.000Z","date":"2024-07-17","kind":"grant","planned":false,"acquired":true,"shares":925,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vest in full on the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vest in full on the first anniversary of the date of grant."}],"balance_after":925,"derivative":{"underlying":"Common Stock","underlying_shares":925},"source":{"system":"sec-edgar","filing":"0000950170-24-084946","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000095017024084946/ownership.xml","form_type":"4"}},{"id":1451190,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25013,"kind":"person","name":"Abdun-Nabi Daniel","position":1,"cik":"0001380187","reported_name":"Abdun-Nabi Daniel","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2024-07-19T20:30:28.000Z","date":"2024-07-17","kind":"grant","planned":false,"acquired":true,"shares":925,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vest in full on the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vest in full on the first anniversary of the date of grant."}],"balance_after":925,"derivative":{"underlying":"Common Stock","underlying_shares":925},"source":{"system":"sec-edgar","filing":"0000950170-24-084944","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000095017024084944/ownership.xml","form_type":"4"}},{"id":1495167,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25011,"kind":"person","name":"Niederhuber John","position":1,"cik":"0001501240","reported_name":"Niederhuber John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2024-06-03T20:58:53.000Z","date":"2024-06-02","kind":"exercise","planned":false,"acquired":false,"shares":81,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On June 2, 2023, the reporting person was granted 3,571 (81 post-split) RSUs, vesting in full on the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On June 2, 2023, the reporting person was granted 3,571 (81 post-split) RSUs, vesting in full on the first anniversary of the date of grant."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":81},"source":{"system":"sec-edgar","filing":"0000950170-24-068075","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000095017024068075/ownership.xml","form_type":"4"}},{"id":1495166,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25011,"kind":"person","name":"Niederhuber John","position":1,"cik":"0001501240","reported_name":"Niederhuber John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2024-06-03T20:58:53.000Z","date":"2024-06-01","kind":"exercise","planned":false,"acquired":false,"shares":7,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On June 1, 2021, the reporting person was granted 893 (20 post-split) RSUs, vesting in three approximately equal annual installments beginning on June 1, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On June 1, 2021, the reporting person was granted 893 (20 post-split) RSUs, vesting in three approximately equal annual installments beginning on June 1, 2022."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":7},"source":{"system":"sec-edgar","filing":"0000950170-24-068075","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000095017024068075/ownership.xml","form_type":"4"}},{"id":1495165,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25011,"kind":"person","name":"Niederhuber John","position":1,"cik":"0001501240","reported_name":"Niederhuber John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-03T20:58:53.000Z","date":"2024-06-02","kind":"exercise","planned":false,"acquired":true,"shares":81,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"On March 5, 2024, the Issuer effected a 1-for-44 reverse stock split of its common stock (the \"Reverse Stock Split\"). The amount of securities reported on this Form 4 have been adjusted to reflect the Reverse Stock Split."}],"balance_after":217,"source":{"system":"sec-edgar","filing":"0000950170-24-068075","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000095017024068075/ownership.xml","form_type":"4"}},{"id":1495164,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25011,"kind":"person","name":"Niederhuber John","position":1,"cik":"0001501240","reported_name":"Niederhuber John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-03T20:58:53.000Z","date":"2024-06-01","kind":"exercise","planned":false,"acquired":true,"shares":7,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"On March 5, 2024, the Issuer effected a 1-for-44 reverse stock split of its common stock (the \"Reverse Stock Split\"). The amount of securities reported on this Form 4 have been adjusted to reflect the Reverse Stock Split."}],"balance_after":136,"source":{"system":"sec-edgar","filing":"0000950170-24-068075","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000095017024068075/ownership.xml","form_type":"4"}},{"id":1495162,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25019,"kind":"person","name":"Harsanyi Zsolt","position":1,"cik":"0001380184","reported_name":"Harsanyi Zsolt","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2024-06-03T20:58:47.000Z","date":"2024-06-02","kind":"exercise","planned":false,"acquired":false,"shares":81,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On June 2, 2023, the reporting person was granted 3,571 (81 post-split) RSUs, vesting in full on the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On June 2, 2023, the reporting person was granted 3,571 (81 post-split) RSUs, vesting in full on the first anniversary of the date of grant."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":81},"source":{"system":"sec-edgar","filing":"0000950170-24-068073","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000095017024068073/ownership.xml","form_type":"4"}},{"id":1495161,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25019,"kind":"person","name":"Harsanyi Zsolt","position":1,"cik":"0001380184","reported_name":"Harsanyi Zsolt","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2024-06-03T20:58:47.000Z","date":"2024-06-01","kind":"exercise","planned":false,"acquired":false,"shares":7,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On June 1, 2021, the reporting person was granted 893 (20 post-split) RSUs, vesting in three approximately equal annual installments beginning on June 1, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On June 1, 2021, the reporting person was granted 893 (20 post-split) RSUs, vesting in three approximately equal annual installments beginning on June 1, 2022."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":7},"source":{"system":"sec-edgar","filing":"0000950170-24-068073","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000095017024068073/ownership.xml","form_type":"4"}},{"id":1495160,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25019,"kind":"person","name":"Harsanyi Zsolt","position":1,"cik":"0001380184","reported_name":"Harsanyi Zsolt","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-03T20:58:47.000Z","date":"2024-06-02","kind":"exercise","planned":false,"acquired":true,"shares":81,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"On March 5, 2024, the Issuer effected a 1-for-44 reverse stock split of its common stock (the \"Reverse Stock Split\"). The amount of securities reported on this Form 4 have been adjusted to reflect the Reverse Stock Split."}],"balance_after":280,"source":{"system":"sec-edgar","filing":"0000950170-24-068073","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000095017024068073/ownership.xml","form_type":"4"}},{"id":1495159,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25019,"kind":"person","name":"Harsanyi Zsolt","position":1,"cik":"0001380184","reported_name":"Harsanyi Zsolt","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-03T20:58:47.000Z","date":"2024-06-01","kind":"exercise","planned":false,"acquired":true,"shares":7,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"On March 5, 2024, the Issuer effected a 1-for-44 reverse stock split of its common stock (the \"Reverse Stock Split\"). The amount of securities reported on this Form 4 have been adjusted to reflect the Reverse Stock Split."}],"balance_after":199,"source":{"system":"sec-edgar","filing":"0000950170-24-068073","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000095017024068073/ownership.xml","form_type":"4"}},{"id":1495158,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25013,"kind":"person","name":"Abdun-Nabi Daniel","position":1,"cik":"0001380187","reported_name":"Abdun-Nabi Daniel","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2024-06-03T20:58:44.000Z","date":"2024-06-02","kind":"exercise","planned":false,"acquired":false,"shares":81,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On June 2, 2023, the reporting person was granted 3,571 (81 post-split) RSUs, vesting in full on the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On June 2, 2023, the reporting person was granted 3,571 (81 post-split) RSUs, vesting in full on the first anniversary of the date of grant."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":81},"source":{"system":"sec-edgar","filing":"0000950170-24-068070","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000095017024068070/ownership.xml","form_type":"4"}},{"id":1495157,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25013,"kind":"person","name":"Abdun-Nabi Daniel","position":1,"cik":"0001380187","reported_name":"Abdun-Nabi Daniel","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2024-06-03T20:58:44.000Z","date":"2024-06-01","kind":"exercise","planned":false,"acquired":false,"shares":7,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On June 1, 2021, the reporting person was granted 893 (20 post-split) RSUs, vesting in three approximately equal annual installments beginning on June 1, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On June 1, 2021, the reporting person was granted 893 (20 post-split) RSUs, vesting in three approximately equal annual installments beginning on June 1, 2022."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":7},"source":{"system":"sec-edgar","filing":"0000950170-24-068070","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000095017024068070/ownership.xml","form_type":"4"}},{"id":1495156,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25013,"kind":"person","name":"Abdun-Nabi Daniel","position":1,"cik":"0001380187","reported_name":"Abdun-Nabi Daniel","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-03T20:58:44.000Z","date":"2024-06-02","kind":"exercise","planned":false,"acquired":true,"shares":81,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"On March 5, 2024, the Issuer effected a 1-for-44 reverse stock split of its common stock (the \"Reverse Stock Split\"). The amount of securities reported on this Form 4 have been adjusted to reflect the Reverse Stock Split."}],"balance_after":277,"source":{"system":"sec-edgar","filing":"0000950170-24-068070","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000095017024068070/ownership.xml","form_type":"4"}},{"id":1495155,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25013,"kind":"person","name":"Abdun-Nabi Daniel","position":1,"cik":"0001380187","reported_name":"Abdun-Nabi Daniel","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-03T20:58:44.000Z","date":"2024-06-01","kind":"exercise","planned":false,"acquired":true,"shares":7,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"On March 5, 2024, the Issuer effected a 1-for-44 reverse stock split of its common stock (the \"Reverse Stock Split\"). The amount of securities reported on this Form 4 have been adjusted to reflect the Reverse Stock Split."}],"balance_after":196,"source":{"system":"sec-edgar","filing":"0000950170-24-068070","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000095017024068070/ownership.xml","form_type":"4"}},{"id":1495154,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25012,"kind":"person","name":"Kunz Barbara Lopez","position":1,"cik":"0001679970","reported_name":"Kunz Barbara Lopez","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2024-06-03T20:58:36.000Z","date":"2024-06-02","kind":"exercise","planned":false,"acquired":false,"shares":81,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On June 2, 2023, the reporting person was granted 3,571 (81 post-split) RSUs, vesting in full on the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On June 2, 2023, the reporting person was granted 3,571 (81 post-split) RSUs, vesting in full on the first anniversary of the date of grant."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":81},"source":{"system":"sec-edgar","filing":"0000950170-24-068068","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000095017024068068/ownership.xml","form_type":"4"}},{"id":1495153,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25012,"kind":"person","name":"Kunz Barbara Lopez","position":1,"cik":"0001679970","reported_name":"Kunz Barbara Lopez","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2024-06-03T20:58:36.000Z","date":"2024-06-01","kind":"exercise","planned":false,"acquired":false,"shares":7,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On June 1, 2021, the reporting person was granted 893 (20 post-split) RSUs, vesting in three approximately equal annual installments beginning on June 1, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On June 1, 2021, the reporting person was granted 893 (20 post-split) RSUs, vesting in three approximately equal annual installments beginning on June 1, 2022."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":7},"source":{"system":"sec-edgar","filing":"0000950170-24-068068","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000095017024068068/ownership.xml","form_type":"4"}}],"next_cursor":"2024-06-03T20:58:36.000000Z,1495153"}